Status:
COMPLETED
Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial
Lead Sponsor:
U.S. Army Medical Research and Development Command
Collaborating Sponsors:
Walter Reed Army Institute of Research (WRAIR)
Royal Thai Ministry of Public Health
Conditions:
HIV-1
Eligibility:
All Genders
18-31 years
Brief Summary
This protocol will study the clinical course of HIV-infection among volunteers who have received either a placebo injection or the experimental vaccine combination of ALVAC-HIV and AIDSVAX B/E prior t...
Detailed Description
Prospective cohort study of the clinical course of HIV-1 infection occurring after candidate HIV-1 vaccination (breakthrough infection) with ALVAC-HIV (vcP1521) and AIDSVAX B/E in reference to study N...
Eligibility Criteria
Inclusion
- All individuals who become HIV-infected after receiving experimental vaccine or placebo in the RV144 clinical trial if they received at least one injection.
- The volunteer must give written, informed consent.
Exclusion
- Persons who have a medical or psychiatric disorder, that in the judgment of the investigator(s), would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent.
- Persons who become HIV-infected after the completion of the RV144 protocol.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00337181
Start Date
May 1 2006
End Date
June 1 2011
Last Update
August 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chon Buri Regional Hospital
Chon Buri, Chon Buri Province, Thailand, 20000